New Data Show Combination Antibody Treatment Reduces Risk of Death in Hospitalized COVID-19 Patients

June 16, 2021 08:15pm

The RECOVERY study demonstrated that an antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for COVID-19 antibody treatments.

New Nonstimulant Medication Is Approved for ADHD in Children
Social Media Incites the COVID-19 Misinformation Epidemic
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy
Pharmacists’ Public Health Role Grows as Birth Control Prescribing Authority Expands